BlackRock Institutional Trust’s Enzymotec Ltd ENZY Stock Holding History

BlackRock Institutional Trust’s Portfolio ENZY Stock Details ENZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$33K	Sell	5,069 -10,720	-68%	-$70.6K	﹤0.01%	3737
2016 Q3	$111K	Sell	15,789 -5,524	-26%	-$44.3K	﹤0.01%	3692
2016 Q2	$178K	Buy	21,313 +2,298	+12%	+$19K	﹤0.01%	3649
2016 Q1	$172K	Buy	19,015 +2,318	+14%	+$20.2K	﹤0.01%	3644
2015 Q4	$164K	Hold	16,697	–	–	﹤0.01%	3684
2015 Q3	$151K	Buy	16,697 +274	+2%	+$2.45K	﹤0.01%	3683
2015 Q2	$137K	Hold	16,423	–	–	﹤0.01%	3685
2015 Q1	$118K	Hold	16,423	–	–	﹤0.01%	3687
2014 Q4	$125K	Sell	16,423 -1,158	-7%	-$8.41K	﹤0.01%	3694
2014 Q3	$117K	Buy	+17,581	New	+$190K	﹤0.01%	3666
2014 Q1	–	Sell	-12,091	Closed	-$327K	–	4084
2013 Q4	$327K	Buy	+12,091	New	+$288K	﹤0.01%	3643

Other funds holding ENZY

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return

Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

BlackRock Institutional Trust's ENZY Position: Q4 2016 in Review

BlackRock Institutional Trust reduced its Enzymotec Ltd (ENZY) stake by 68% in Q4 2016, selling an estimated $70.6K and leaving 5,069 shares worth $33K. The position accounts for ﹤0.01% of the portfolio, ranked #3737.

BlackRock Institutional Trust first reported a position in ENZY in Q4 2013 and has held it in 11 quarters since. The position peaked at $327K in Q4 2013. 32 funds tracked by Wall St. Rank hold ENZY as of Q4 2016.

BlackRock Institutional Trust held 5,069 shares of Enzymotec Ltd worth $33K as of Q4 2016.
BlackRock Institutional Trust sold 10,720 Enzymotec Ltd shares in Q4 2016, an estimated $70.6K.
Enzymotec Ltd made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3737 holding.
BlackRock Institutional Trust first reported a position in Enzymotec Ltd in Q4 2013 and has held it in 11 quarters since.
BlackRock Institutional Trust's Enzymotec Ltd position peaked at $327K in Q4 2013.
32 funds tracked by Wall St. Rank held Enzymotec Ltd as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.